Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Apelin vs TB-500
An educational, source-based comparison of Apelin and TB-500 — how each peptide works, what it's researched for, and what to know before going deeper.
An endogenous peptide ligand for the APJ receptor, widely expressed in cardiovascular and metabolic tissues. Research indicates roles in cardiac contractility, angiogenesis, blood pressure regulation, and insulin sensitivity.
- Heart failure and cardiac contractility
- Pulmonary arterial hypertension
- Insulin sensitivity and glucose uptake
- Angiogenesis and vascular repair
- • Primarily preclinical and early clinical research.
- • Not FDA-approved for any indication.
Synthetic fragment of Thymosin Beta-4 studied for tissue and vascular repair.
A synthetic peptide fragment of Thymosin Beta-4 (Tβ4). Research suggests it upregulates actin, promotes cell migration, angiogenesis, and modulates inflammation — supporting repair in muscle, tendon, cardiac, and corneal tissue models.
- Muscle and tendon repair
- Cardiac tissue recovery (preclinical)
- Corneal and dermal wound healing
- Hair follicle stem cell activation
- • Not FDA-approved; banned by WADA.
- • Most evidence is preclinical.
Apelin vs TB-500 — Key differences
- Class: Apelin is classified as Cardiovascular · Metabolic, while TB-500 is Tissue Repair · Vascular.
- Primary research focus: Apelin — heart failure and cardiac contractility; TB-500 — muscle and tendon repair.
- Tag: Cardiovascular · Metabolic vs Recovery.